ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
Authors
Keywords
Metalloproteinase, Disintegrin, Alternative splicing, microRNA, Post-transcriptional gene regulation, Breast cancer, Claudin-low tumors, Epithelial-to-mesenchymal transition
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-03-03
DOI
10.1186/s12885-015-1108-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
- (2014) M K Nygren et al. BRITISH JOURNAL OF CANCER
- Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
- (2014) Renaud Sabatier et al. Molecular Cancer
- Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12
- (2014) Yue Qi et al. PLoS One
- Canonical Transforming Growth Factor-β Signaling Regulates Disintegrin Metalloprotease Expression in Experimental Renal Fibrosis via miR-29
- (2013) Vasudev Ramdas et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells
- (2013) Maria Ouzounova et al. BMC GENOMICS
- Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype
- (2013) Hui Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
- (2013) Aleix Prat et al. BREAST CANCER RESEARCH AND TREATMENT
- Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis
- (2013) J. Chuck Harrell et al. CLINICAL & EXPERIMENTAL METASTASIS
- The Role of MicroRNAs in Breast Cancer Stem Cells
- (2013) Daniela Schwarzenbacher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression
- (2013) Jonathan Chou et al. NATURE CELL BIOLOGY
- Alternative mRNA Splicing Generates Two Distinct ADAM12 Prodomain Variants
- (2013) Sara Duhachek-Muggy et al. PLoS One
- An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer
- (2012) Hui Li et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA regulation of epithelial plasticity in cancer
- (2012) Nicholas C. D’Amato et al. CANCER LETTERS
- Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
- (2012) D M Cittelly et al. ONCOGENE
- Functional Analysis of a Breast Cancer-Associated Mutation in the Intracellular Domain of the Metalloprotease ADAM12
- (2012) Dorte Stautz et al. PLoS One
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
- (2011) Christina Scheel et al. CELL
- Metalloprotease-Disintegrin ADAM12 Expression Is Regulated by Notch Signaling via MicroRNA-29
- (2011) Hui Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. MOLECULAR BIOLOGY OF THE CELL
- ADAM12 Produced by Tumor Cells Rather than Stromal Cells Accelerates Breast Tumor Progression
- (2011) C. Frohlich et al. MOLECULAR CANCER RESEARCH
- miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
- (2011) Espen Enerly et al. PLoS One
- Regulation of mRNA Translation and Stability by microRNAs
- (2010) Marc Robert Fabian et al. Annual Review of Biochemistry
- microRNAs and EMT in Mammary Cells and Breast Cancer
- (2010) Josephine A. Wright et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells
- (2010) F Yu et al. ONCOGENE
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- (2010) J. H. Taube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
- (2009) Yohei Shimono et al. CELL
- Targeting ADAM12 in Human Disease: Head, Body or Tail?
- (2009) J. Jacobsen et al. CURRENT PHARMACEUTICAL DESIGN
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
- (2009) Pierre Farmer et al. NATURE MEDICINE
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways
- (2008) T. T. Onder et al. CANCER RESEARCH
- Cellular roles of ADAM12 in health and disease
- (2008) Marie Kveiborg et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein
- (2008) Emilia Dyczynska et al. INTERNATIONAL JOURNAL OF CANCER
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now